The Exon 3-Deleted/Full-Length Growth Hormone Receptor Polymorphism and Response to Growth Hormone Therapy in Growth Hormone Deficiency and Turner Syndrome: A Multicenter Study

Publisher： Karger

E-ISSN： 1663-2826|77|2|85-93

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.77, Iss.2, 2012-03, pp. : 85-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth Hormone Therapy in Patients with Turner Syndrome

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 2, 2004-11 ,pp. : 62-66

Karger

Access to resources Recommend Favorite

The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis

By  

Neuroendocrinology, Vol. 105, Iss. 2, 2016-08 ,pp. : 131-140

Karger

Access to resources Recommend Favorite

Growth Hormone Receptor Exon 3 Isoforms and Their Implication in Growth Disorders and Treatment

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 2, 2009-04 ,pp. : 55-63

Karger

Access to resources Recommend Favorite

Height Gains in Response to Growth Hormone Treatment to Final Height Are Similar in Patients with SHOX Deficiency and Turner Syndrome

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 3, 2009-02 ,pp. : 167-172

Karger

Access to resources Recommend Favorite

Cardiac Performance in Turner’s Syndrome Patients on Growth Hormone Therapy

By  

Hormone Research in Paediatrics, Vol. 55, Iss. 5, 2001-12 ,pp. : 240-244

Karger

Access to resources Recommend Favorite